Calamos Advisors’s Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant NGC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,129
Closed -$178K 1467
2022
Q2
$178K Hold
18,129
﹤0.01% 1125
2022
Q1
$187K Hold
18,129
﹤0.01% 1128
2021
Q4
$183K Hold
18,129
﹤0.01% 1097
2021
Q3
$181K Hold
18,129
﹤0.01% 962
2021
Q2
$183K Hold
18,129
﹤0.01% 935
2021
Q1
$181K Buy
+18,129
New +$180K ﹤0.01% 891

Other funds holding NGC.U

Calamos Advisors's NGC.U Position: Q3 2022 in Review

Calamos Advisors sold out of Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant (NGC.U) in Q3 2022, closing a stake of 18,129 shares — an estimated $178K sold.

Calamos Advisors first reported a position in NGC.U in Q1 2021 and held it in 6 quarters. The position peaked at $187K in Q1 2022. 10 funds tracked by Wall St. Rank hold NGC.U as of Q3 2022.

  • Calamos Advisors reported no remaining Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 18,129 Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant shares in Q3 2022, an estimated $178K.
  • Calamos Advisors first reported a position in Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 6 quarters.
  • Calamos Advisors's Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position peaked at $187K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.